Historical shareholding details of Bridgeway Capital Management, LLC holdings in Gain Therapeutics Inc (GANX)

Monthly changes of Bridgeway Capital Management, LLC shareholding in Gain Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Bridgeway Capital Management, Llc 30,004 0.11%
Jan 31, 2025 Bridgeway Capital Management, Llc 30,004 0.11%
Dec 31, 2024 Bridgeway Capital Management, Llc 30,004 0.11%
Dec 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Nov 30, 2024 Bridgeway Capital Management, Llc 0 0.00%
Oct 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Sep 30, 2024 Bridgeway Capital Management, Llc 0 0.00%
Sep 30, 2024 Bridgeway Capital Management, Llc 40,000 0.16%
Aug 31, 2024 Bridgeway Capital Management, Llc 40,000 0.16%
Jul 31, 2024 Bridgeway Capital Management, Llc 40,000 0.16%
Jun 30, 2024 Bridgeway Capital Management, Llc 40,000 0.16%
Jun 30, 2024 Bridgeway Capital Management, Llc 30,000 0.12%
May 31, 2024 Bridgeway Capital Management, Llc 30,000 0.17%
Apr 30, 2024 Bridgeway Capital Management, Llc 46,100 0.28%
Mar 31, 2024 Bridgeway Capital Management, Llc 30,000 0.11%
Mar 31, 2024 Bridgeway Capital Management, Llc 46,100 0.28%
Feb 29, 2024 Bridgeway Capital Management, Llc 46,100 0.28%
Jan 31, 2024 Bridgeway Capital Management, Llc 46,100 0.28%
Dec 31, 2023 Bridgeway Capital Management, Llc 46,100 0.26%
Dec 31, 2023 Bridgeway Capital Management, Llc 46,100 0.28%
Nov 30, 2023 Bridgeway Capital Management, Llc 46,100 0.29%
Oct 31, 2023 Bridgeway Capital Management, Llc 46,100 0.36%
Sep 30, 2023 Bridgeway Capital Management, Llc 46,100 0.29%
Sep 30, 2023 Bridgeway Capital Management, Llc 46,100 0.36%
Aug 31, 2023 Bridgeway Capital Management, Llc 46,100 0.36%
Jul 31, 2023 Bridgeway Capital Management, Llc 60,000 0.49%
Jun 30, 2023 Bridgeway Capital Management, Llc 46,100 0.36%
Jun 30, 2023 Bridgeway Capital Management, Llc 60,000 0.49%
May 31, 2023 Bridgeway Capital Management, Llc 60,000 0.49%
Mar 31, 2023 Bridgeway Capital Management, Llc 60,000 0.49%

View all ownership details of Gain Therapeutics Inc